People: Plethora Solutions Holdings PLC (PLE.L)

PLE.L on London Stock Exchange

6.50GBp
21 Nov 2014
Price Change (% chg)

-0.25p (-3.70%)
Prev Close
6.75p
Open
6.75p
Day's High
--
Day's Low
--
Volume
1,703,584
Avg. Vol
3,544,854
52-wk High
18.85p
52-wk Low
5.50p

Search Stocks

Summary

Name Age Since Current Position

James Mellon

57 2013 Non-Executive Chairman of the Board

Jamie Gibson

47 2014 Chief Executive Officer, Executive Director

Michael Collis

2013 Chief Financial Officer, Executive Director

Michael Wyllie

Chief Scientific Officer, Executive Director

Romero Tayong

2013 Company Secretary

Gregory Bailey

56 2013 Non-Executive Director

Biographies

Name Description

James Mellon

Sir James Mellon is Non-Executive Chairman of the Board of Plethora Solutions Holdings Plc., since April 12, 2013. JimMellon is an investor with interests in several industries. After leaving Oxford, where he studied PPE, he worked in Asia and the United States in two fund management companies, GT and Thornton, before establishing his own business in 1991. This now has two components: a listed fundmanagement company, Charlemagne Capital; and an Asian investment group, Regent Pacific. In addition, Jim is the controlling shareholder and a director of Manx Financial Corporation, an Isle of Man-based bank; Speymill Group, a property business; and Webis Holdings; and a co-founder of Uramin and Red Dragon Resources, both mining groups. Burnbrae, his private company, is a substantial landlord in Germany and in the Isle of Man, and it owns outright the hotel chain, Sleepwell Hotels Limited. Jim spends most of his time working on startup ideas and on investing. His first book, ‘Wake Up!’ was published in 2005, and the second, ‘10 Investments for the Ten Years Ahead’, in 2008. Jim lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Jamie Gibson

Mr. Jamie Alexander Gibson is Chief Executive Officer, Executive Director of the Company since January 1, 2014. Jamie Gibson is the CEO and Executive Director of Regent Pacific Group Limited (“Regent Pacific”), which is a substantial shareholder in the Company. Mr. Gibson has spent most of his professional career with Regent Pacific specialising in corporate finance, direct equity investments and structuring emerging market investment products. Prior to joining Regent Pacific, he worked at Clifford Chance, Coopers & Lybrand and KPMG. Mr. Gibson has a law degree from Edinburgh University. He is also director of a number of subsidiaries of Regent Pacific Group, including Amerinvest Coal Industry Holding Company Limited, which in turn holds a 25% equity interest in West China Coking & Gas Company Limited. Mr. Gibson was formerly: (i) a non-executive director of BC Iron Limited (“BCI”, a company listed on the Australian Securities Exchange (“ASX”)), having been appointed on 16 July 2012, representing Regent Pacific’s 23.11 per cent interest then held in BCI, and resigned on 18 December 2012 in anticipation of the company’s contemplated disposal of its entire interest in BCI; and (ii) the alternate director to James Mellon on the board of Venturex Resources Limited (a company listed on ASX), having been appointed on 12 March 2013 and resigned on 10 June 2013.

Michael Collis

Mr. Michael Collis is Chief Financial Officer, Executive Director of Plethora Solutions Holdings PLC. Mike Collis is an advisor to Maven Capital Partners (UK) LLP (“Maven”), which manages the Capital for Enterprise Fund (“CfE”). CfE provided a £1m facility to the Company under which it has the right to appoint a director to the board. Mr Collis is a Chartered Accountant and a specialist in business turnarounds and holds a practicing certificate with the Institute for Turnaround. He is managing director of Arc Portfolio Management Limited. He was previously Head of Portfolio Management at Aberdeen Asset Managers Private Equity. He has served on the boards of a number of private companies often as a nominee of the investor. Mr Collis qualified as a Chartered Accountant with Arthur Andersen.

Michael Wyllie

Dr. Michael Grant Wyllie, Ph.D., is Chief Scientific Officer, Executive Director of Plethora Solutions Holdings plc. Dr. Mike Wyllie is a co-founder of Plethora Solutions Holdings plc. He has over 25 years of experience in senior management level positions within the pharmaceutical industry, with American Home Products and Pfizer. He has considerable hands-on experience in all aspects of the drug discovery and development process, and has been involved with new project inception, drug discovery and safety testing, early and late stage clinical development, regulatory filing, and the successful commercialisation of products, including Cardura® (doxazosin) and Viagra® (sildenafil). Mike sits on the Clinical Trial Design and Future Therapies in BPH Committees of the World Health Organisation International Consultations on Urological Disease, and he is an assistant editor of the British Journal of Urology in the Sexual Medicine Section. He has over 100 publications and is the named inventor of over 80 patents. He is an independent director on the board of the NASDAQ listed reproductive health company, Repros (“RPRX”).

Romero Tayong

Mr. Romero Tayong is Company Secretary of the Company since December 1, 2013. He has been Financial Controller of the Company and has worked with the Company since 2008. He is a Certified Accountant.

Gregory Bailey

Dr. Gregory H. Bailey, M.D., is Non-Executive Director of Plethora Solutions Holdings plc. Dr. Bailey is managing partner of Palantir Group, Inc., a merchant bank specialising in biotech and intellectual property and is chairman of Portage Biotech, Inc. a publicly traded drug development company. Dr. Bailey has over fifteen years’ experience in investment banking and has also founded several companies. Along with comprehensive experience in healthcare, finance and medicine Dr. Bailey also brings to the board of directors an extensive involvement in corporate governance. Dr. Bailey has served on multiple public company boards of directors. Dr. Bailey was a practicing physician for ten years and holds a M.D. degree from the University of Western Ontario.

Basic Compensation

Name Fiscal Year Total

James Mellon

38,000

Jamie Gibson

--

Michael Collis

34,000

Michael Wyllie

199,000

Romero Tayong

--

Gregory Bailey

--
As Of 30 Dec 2013

Options Compensation

Search Stocks